Paper32905502
Organoid models of glioblastoma: advances, applications and challenges.
Zhang C and 4 others. Am J Cancer Res, 2020. Cited by 37 papers, by iCite.
Cite this record
ConductScience Library. Organoid models of glioblastoma: advances, applications and challenges. Papers, record 32905502. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32905502
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References110
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19398967 | Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche. | Nat Med | 2009 | https://conductscience.org/library/papers/19398967 | PubMed |
| 2 | 25957691 | Prospective derivation of a living organoid biobank of colorectal cancer patients. | Cell | 2015 | https://conductscience.org/library/papers/25957691 | PubMed |
| 3 | 28652918 | Engineering CAR-T cells. | Biomark Res | 2017 | https://conductscience.org/library/papers/28652918 | PubMed |
| 4 | 32123335 | Fast and efficient generation of knock-in human organoids using homology-independent CRISPR-Cas9 precision genome editing. | Nat Cell Biol | 2020 | https://conductscience.org/library/papers/32123335 | PubMed |
| 5 | 26644564 | Human cerebral organoids recapitulate gene expression programs of fetal neocortex development. | Proc Natl Acad Sci U S A | 2015 | https://conductscience.org/library/papers/26644564 | PubMed |
| 6 | 29788550 | Ubiquitin-specific protease 22 acts as an oncoprotein to maintain glioma malignancy through deubiquitinating B cell-specific Moloney murine leukemia virus integration site 1 for stabilization. | Cancer Sci | 2018 | https://conductscience.org/library/papers/29788550 | PubMed |
| 7 | 28426845 | HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial. | JAMA Oncol | 2017 | https://conductscience.org/library/papers/28426845 | PubMed |
| 8 | 25533785 | Long-term culture of genome-stable bipotent stem cells from adult human liver. | Cell | 2015 | https://conductscience.org/library/papers/25533785 | PubMed |
| 9 | 31139410 | Clinical chimeric antigen receptor-T cell therapy: a new and promising treatment modality for glioblastoma. | Clin Transl Immunology | 2019 | https://conductscience.org/library/papers/31139410 | PubMed |
| 10 | 31996670 | Modeling medulloblastoma in vivo and with human cerebellar organoids. | Nat Commun | 2020 | https://conductscience.org/library/papers/31996670 | PubMed |
| 11 | 28697965 | Beyond organoids: In vitro vasculogenesis and angiogenesis using cells from mammals and zebrafish. | Reprod Toxicol | 2017 | https://conductscience.org/library/papers/28697965 | PubMed |
| 12 | 32209439 | Organoids: A Platform Ready for Glioblastoma Precision Medicine? | Trends Cancer | 2020 | https://conductscience.org/library/papers/32209439 | PubMed |
| 13 | 25043003 | Genome sequencing of normal cells reveals developmental lineages and mutational processes. | Nature | 2014 | https://conductscience.org/library/papers/25043003 | PubMed |
| 14 | 28029927 | Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy. | N Engl J Med | 2016 | https://conductscience.org/library/papers/28029927 | PubMed |
| 15 | 32297954 | Modeling glioblastoma invasion using human brain organoids and single-cell transcriptomics. | Neuro Oncol | 2020 | https://conductscience.org/library/papers/32297954 | PubMed |
| 16 | 27919796 | The bad seed gardener: Deubiquitinases in the cancer stem-cell signaling network and therapeutic resistance. | Pharmacol Ther | 2017 | https://conductscience.org/library/papers/27919796 | PubMed |
| 17 | 29664018 | Increased vessel perfusion predicts the efficacy of immune checkpoint blockade. | J Clin Invest | 2018 | https://conductscience.org/library/papers/29664018 | PubMed |
| 18 | 25521283 | Spatially gradated hydrogel platform as a 3D engineered tumor microenvironment. | Adv Mater | 2015 | https://conductscience.org/library/papers/25521283 | PubMed |
| 19 | 26806352 | A Novel Mouse Model of Diffuse Intrinsic Pontine Glioma Initiated in Pax3-Expressing Cells. | Neoplasia | 2016 | https://conductscience.org/library/papers/26806352 | PubMed |
| 20 | 26896279 | A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo. | Cancer Res | 2016 | https://conductscience.org/library/papers/26896279 | PubMed |
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42693244 | Integrating ex vivo platforms with AI to guide glioblastoma treatment. | J Neurooncol | 2026 | https://conductscience.org/library/papers/42693244 | PubMed |
| 42218467 | Organoids as next-generation models for investigating intracranial tumours. | Mol Brain | 2026 | https://conductscience.org/library/papers/42218467 | PubMed |
| 41993610 | Translational Models for Glioblastoma: Revolutionizing Drug Development and Personalized Medicine through Clinical Insights. | Theranostics | 2026 | https://conductscience.org/library/papers/41993610 | PubMed |
| 41789657 | Cellular and inflammatory characteristics of patient‑derived glioblastoma organoids during in vitro cultivation. | Oncol Rep | 2026 | https://conductscience.org/library/papers/41789657 | PubMed |
| 41226697 | Modeling Glioblastoma with Brain Organoids: New Frontiers in Oncology and Space Research. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41226697 | PubMed |
| 40548110 | Development and validation of a deep learning algorithm for discriminating glioma recurrence from radiation necrosis on MRI. | Front Oncol | 2025 | https://conductscience.org/library/papers/40548110 | PubMed |
| 40183896 | Evolution of Preclinical Models for Glioblastoma Modelling and Drug Screening. | Curr Oncol Rep | 2025 | https://conductscience.org/library/papers/40183896 | PubMed |
| 39963753 | Targeting PGE2 mediated senescent neuron improves tumor therapy. | Neuro Oncol | 2025 | https://conductscience.org/library/papers/39963753 | PubMed |
| 39813590 | Engineered Cell Microenvironments: A Benchmark Tool for Radiobiology. | ACS Appl Mater Interfaces | 2025 | https://conductscience.org/library/papers/39813590 | PubMed |
| 39553223 | Generation and banking of patient-derived glioblastoma organoid and its application in cancer neuroscience. | Am J Cancer Res | 2024 | https://conductscience.org/library/papers/39553223 | PubMed |
| 39292297 | A reference for selecting an appropriate method for generating glioblastoma organoids from the application perspective. | Discov Oncol | 2024 | https://conductscience.org/library/papers/39292297 | PubMed |
| 39240627 | Glioma stem cells remodel immunotolerant microenvironment in GBM and are associated with therapeutic advancements. | Cancer Biomark | 2024 | https://conductscience.org/library/papers/39240627 | PubMed |
| 39185670 | Microbiota and glioma: a new perspective from association to clinical translation. | Gut Microbes | 2024 | https://conductscience.org/library/papers/39185670 | PubMed |
| 38474286 | Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38474286 | PubMed |
| 38435477 | Personalized Medicine in Brain Gliomas: Targeted Therapy, Patient-Derived Tumor Models (Review). | Sovrem Tekhnologii Med | 2023 | https://conductscience.org/library/papers/38435477 | PubMed |
| 38394389 | A 3D Bioprinted Human Neurovascular Unit Model of Glioblastoma Tumor Growth. | Adv Healthc Mater | 2024 | https://conductscience.org/library/papers/38394389 | PubMed |
| 38017433 | Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy. | Mol Cancer | 2023 | https://conductscience.org/library/papers/38017433 | PubMed |
| 37928397 | Non-animal glioblastoma models for personalized treatment. | Heliyon | 2023 | https://conductscience.org/library/papers/37928397 | PubMed |
| 37901257 | Engineering the glioblastoma microenvironment with bioactive nanoparticles for effective immunotherapy. | RSC Adv | 2023 | https://conductscience.org/library/papers/37901257 | PubMed |
| 37389023 | Development of a 3D Tumor Spheroid Model from the Patient's Glioblastoma Cells and Its Study by Metabolic Fluorescence Lifetime Imaging. | Sovrem Tekhnologii Med | 2023 | https://conductscience.org/library/papers/37389023 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32905502
GET https://conductscience.org/api/papers/v1/32905502/references?page=2